Recent Publications and Presentations
Sereti I, Sklar P, Ramchandani MS, Read SW, Aggarwal V, Imamichi H, Natarajan V, Metcalf JA, Joseph A. Kovacs JA, Tavel J, Davey RT, DerSimonian R, Lane HC (2007). CD4+ T Cell Responses to Interleukin-2 Administration in HIV-Infected Patients Are Directly Related to the Baseline Level of Immune Activation. The Journal of Infectious Diseases, 196: 677-683.
DerSimonian, R., Kacker, R. (2007). Random-Effects Model for Meta-Analysis of Clinical Trials: An Update. Contemporary Clinical Trials, 28: 105-114.
Follmann, Dean (2006). Augmented Designs to Assess Immune Response in Vaccine Trials. The International Biometric Society.
Fay, M.P. (2005). Random Marginal Agreement Coefficients: Rethinking the Adjustment for Chance when Measuring Agreement. Biostatistics 6, 171-180.
Brownstein, C.M., Mertens, A.C., et al (2004). Factors That Affect Final Height and Change in Height Standard Deviation Scores in Survivors of Childhood Cancer Treated with Growth Hormone: A Report from the Childhood Cancer Survivor Study. The Journal of Clinical Endocrinology & Metabolism 89, 4422-4427.
Chun TW, Justement JS, et al (2004). Relationship between the frequency of HIV-specific CD8(+) T cells and the level of CD38(+)CD8(+) T cells in untreated HIV-infected individuals. P Natl Acad Sci 101, 2464-2469.
Dybul M, Nies-Kraske E, et al (2004). A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for treatment of chronic HIV infection. Journal of Infectious Diseases 189, 1974-1982.
Farel, C.E., Chaitt, D.G., et al (2004). Induction and Maintenance Therapy with Intermittent Interleukin-2 in HIV-1 Infection. Blood 103, 3282-3286.
Houldsworth, J., Olshen, A.B., et al (2004). Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood 103, 1862-1868.
Huang, H-Y., Lal, P., et al (2004). Low-Grade Myxofibrosarcoma: A Clinicopathologic Analysis of 49 Cases Treated at a Single Institution With Simultaneous Assessment of the Efficacy of 3-Tier and 4-Tier Grading Systems. Hum Pathol 35, 612-621.
Kim, H-J., Fay, M.P., et al (2004). Comparability of Segmented Line Regression Models. Biometrics 60, 1005-1014.
Kottilill S, Shin K, et al (2004). Expression of chemokine and inhibitory receptors on natural killer cells: Effect of immune activation and HIV viremia. J of Infectious Diseases 189, 1193-1198.
Kuramoto, K., Follmann, D.A., et al (2004). Effect of Chronic Cytokine Therapy on Clonal Dynamics in Nonhuman Primates. Blood 103, 4070-4077.
Kuramoto, K., Follmann, D.A., et al (2004). The Impact of Low-dose Busulfan on Clonal Dynamics in Nonhuman Primates. Blood 104, 1273-1280.
Nakamura, R., Battiwalla, M., et al (2004). Persisting Posttransplantation Cytomegalovirus Antigenemia Correlates with Poor Lymphocyte Proliferation to Cytomegalovirus Antigen and Predicts for Increased Late Relapse and Treatment Failure. Biology of Blood and Marrow Transplantation 10, 49-57.
Nason, M., Emerson, S., and LeBlanc, M. (2004). CARTscans: A Tool for Visualizing Complex Models. Journal of Computational and Graphical Statistics 13, 807-825.
Portlock, C.S., Donnelly, G.B., et al (2004). Adverse Prognostic Significance of CD20 Positive Reed-Sternberg Cells in Classical Hodgkin's Disease. British Journal of Haematology 125, 701-708.
Proschan, M.A. and Follmann, D.A. (2004). A Permutation Approach To The Behrens-Fisher Problem. Journal of the Korean Statistical Society 33, 79-97.
Radimer, K.L., Ballard-Barbash, R., et al (2004). Weight Change and the Risk of Late Onset Breast Cancer in the Original Framingham Cohort. Nutrition and Cancer 49, 7-13.
Sereti I, Anthon KB, et al (2004). IL2-Induced CD4+ T cell expansion in HIV-infected patients is associated with decreased T cell proliferation. Blood Journal 104, 775-780.
Sereti, I., Anthony, K.B., et al (2004). IL-2-Induced CD4+ T-cell Expansion in HIV-infected Patients is Associated with Long-term Decreases in T-cell Proliferation. Blood 104, 775-780.
Stylianou, M. and Follmann, D.A. (2004). The Accelerated Biased Coin Up-and-Down Design in Phase I Trials. Journal of Biopharmaceutical Statistics 14, 249-260.
back to top